ILMN vs MEDP

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 13, 2026

ILMN

39.0
AI Score
VS
MEDP Wins

MEDP

42.3
AI Score

Investment Advisor Scores

ILMN

39score
Recommendation
SELL

MEDP

42score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ILMN MEDP Winner
Revenue 1.41B 2.25B ILMN
Net Income 245.23M 340.00M ILMN
Net Margin 17.3% 15.1% MEDP
Operating Income 288.33M 454.00M ILMN
ROE 56.5% 12.0% MEDP
ROA 11.9% 5.1% MEDP
Total Assets 2.06B 6.65B ILMN
Current Ratio 0.73 1.80 ILMN
Free Cash Flow 283.07M 412.00M ILMN

Relative Price Performance (Last 90 Days)

ILMN 1M: +7.0% · 3M: +24.2% MEDP 1M: -1.6% · 3M: +23.7%

Current Technical Phase

ILMN

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 49.5 · Price: $206.45

MEDP

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 48.9 · Price: $587.52

Fundamentals Snapshot

Metric ILMN MEDP
Market Cap
Forward P/E 33.9 30.4
Trailing P/E 37.6 34.5
Revenue (TTM)
Revenue Growth 0.1% 0.2%
Gross Margin 0.7% 0.7%
Operating Margin 0.2% 0.2%
EPS 5.35 16.91
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, MEDP is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.